Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
June 10 (Bloomberg) -- Bloomberg's Anna Edwards reports that AstraZeneca has agreed to a $1.15 billion deal to buy Pearl Therapeutics, a maker of therapies for respiratory disease. She speaks on Bloomberg Television's "Countdown."
On Air Now
On the Move with Rishaad Salamat
Max 250 characters
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC